anti-cd19 fast car-t cells
Cell therapyexperimental
Clinical trial activity
1 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 21, 2020 (NCT04638270)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- B-lymphocyte antigen CD19Immunity, passive
CD19 immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04638270 | Early Phase 1 (Phase 1) | Nov 21, 2020 | Chongqing Medical University, Gracell Biotechnology Ltd., Guizhou Medical University, Kunming Medical University, People's Liberation Army of China |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chongqing Medical University | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Gracell Biotechnology Ltd. | For profit | 1 | 0 | 1 | 2020 |
| Guizhou Medical University | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Kunming Medical University | Academic/Hospital | 1 | 0 | 1 | 2020 |
| People's Liberation Army of China | Government | 1 | 1 | 1 | 2020 |
5 organizations
Page 1 / 1